Clinical Trials in New York

Showing 15661-15680 of 22,668 trials

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

NCT02583919

The purpose of this study is to evaluate the efficacy, safety, and tolerability of ISIS-GCGRRx in combination with metformin versus placebo

Type 2 Diabetes

Ionis Pharmaceuticals, Inc.79 participantsStarted Sep 2015

Greenbrae, California, United States • Huntington Park, California, United States • La Mesa, California, United States +16 more locations

COMPLETEDPhase 2< 1 mile

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

NCT01985126

The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at least 3 prior lines of therapy (including a proteasome inhibitor \[PI\] and immunomodulatory drug \[IMiD\]) or are double refractory to a PI and an IMiD.

Multiple Myeloma

Janssen Research & Development, LLC124 participantsStarted Sep 2013

Duarte, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +20 more locations

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Find Trials by Condition in New York

Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

Evaluation of Etafilcon A Daily Disposable Lenses

Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY

Clinical Performance Comparison of Two Contact Lenses

Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Improve Hypertension Monitoring and Self-management by Using mHealth

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis